{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:08Z","timestamp":1791357248782,"version":"4.3.1"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/gco.0b013e328348a3ce","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T08:00:51Z","timestamp":1307692851000},"page":"238-244","source":"Crossref","is-referenced-by-count":39,"title":["Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists"],"prefix":"10.1097","volume":"23","author":[{"given":"Orkun","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Bukulmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.med.45.1.391","article-title":"Gonadotropin-releasing hormone and its analogs.","volume":"45","author":"Conn","year":"1994","journal-title":"Annu Rev Med"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2265.2002.01291.x","article-title":"Clinical use of GnRH analogues.","volume":"56","author":"Kiesel","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1701-2163(16)30206-7","article-title":"Gonadotropin-releasing hormone and reproductive medicine.","volume":"25","author":"Shalev","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1073\/pnas.95.1.305","article-title":"Second gene for gonadotropin-releasing hormone in humans.","volume":"95","author":"White","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-5793(99)01638-5","article-title":"The gonadotropin-releasing hormone family of neuropeptides in the brain of human, bovine and rat: identification of a third isoform.","volume":"463","author":"Yahalom","year":"1999","journal-title":"FEBS Lett"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/er.2003-0039","article-title":"Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans.","volume":"26","author":"Cheng","year":"2005","journal-title":"Endocr Rev"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/er.2003-0002","article-title":"Gonadotropin-releasing hormone receptors.","volume":"25","author":"Millar","year":"2004","journal-title":"Endocr Rev"},{"key":"R9-6-20210129","first-page":"161","article-title":"Expression and signal transduction pathways of gonadotropin-releasing hormone receptors.","volume":"50","author":"Stojilkovic","year":"1995","journal-title":"Recent Prog Horm Res"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1095\/biolreprod59.3.661","article-title":"Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle.","volume":"59","author":"Raga","year":"1998","journal-title":"Biol Reprod"},{"key":"R11-6-20210129","first-page":"1377","article-title":"Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation.","volume":"85","author":"Casan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/gyno.1994.1006","article-title":"GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience.","volume":"52","author":"Peterson","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1677\/erc.1.01033","article-title":"Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.","volume":"13","author":"Kim","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1126\/science.6985750","article-title":"Placental luteinizing hormone-releasing factor and its synthesis.","volume":"207","author":"Khodr","year":"1980","journal-title":"Science"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0015-0282(16)44236-6","article-title":"Extrahypothalamic luteinizing hormone-releasing factor (LRF): release of immunoreactive LRF in vitro.","volume":"32","author":"Siler-Khodr","year":"1979","journal-title":"Fertil Steril"},{"key":"R16-6-20210129","first-page":"242","article-title":"Effect of GnRH on guinea pig endometrium at preimplantation stage.","volume":"45","author":"Jelodar","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/molehr\/5.3.234","article-title":"GnRH mRNA and protein expression in human preimplantation embryos.","volume":"5","author":"Casan","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/me.2010-0334","article-title":"37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.","volume":"25","author":"Poon","year":"2011","journal-title":"Mol Endocrinol"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejogrb.2009.11.009","article-title":"GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.","volume":"149","author":"Serin","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/molehr\/7.5.447","article-title":"Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle.","volume":"7","author":"Cheon","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1210\/jcem.86.10.8100","article-title":"Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells.","volume":"86","author":"Choi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1210\/endo.142.1.7895","article-title":"Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells.","volume":"142","author":"Kang","year":"2001","journal-title":"Endocrinology"},{"key":"R24-6-20210129","first-page":"1036","article-title":"Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2.","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res"},{"key":"R25-6-20210129","first-page":"2577","article-title":"Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines.","volume":"51","author":"Harris","year":"1991","journal-title":"Cancer Res"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/mend.14.5.0464","article-title":"Identification of Phe313 of the gonadotropin-releasing hormone (GnRH) receptor as a site critical for the binding of nonpeptide GnRH antagonists.","volume":"14","author":"Cui","year":"2000","journal-title":"Mol Endocrinol"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/edrv.18.2.0295","article-title":"Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor.","volume":"18","author":"Sealfon","year":"1997","journal-title":"Endocr Rev"},{"key":"R28-6-20210129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/edrv-15-4-462","article-title":"Gonadotropin-releasing hormone receptors: structure and signal transduction pathways.","volume":"15","author":"Stojilkovic","year":"1994","journal-title":"Endocr Rev"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1074\/jbc.275.13.9193","article-title":"Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q11) proteins.","volume":"275","author":"Grosse","year":"2000","journal-title":"J Biol Chem"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1074\/jbc.272.21.13534","article-title":"Differential activation of protein kinase C delta and epsilon gene expression by gonadotropin-releasing hormone in alphaT3-1 cells. Autoregulation by protein kinase C.","volume":"272","author":"Harris","year":"1997","journal-title":"J Biol Chem"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/joe.0.1130317","article-title":"Specific binding sites for gonadotrophin-releasing hormone, LHchorionic gonadotrophin, low-density lipoprotein, prolactin and FSH in homogenates of human corpus luteum. II: concentrations throughout the luteal phase of the menstrual cycle and early pregnancy.","volume":"113","author":"Bramley","year":"1987","journal-title":"J Endocrinol"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0277-5379(89)90011-4","article-title":"Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata.","volume":"25","author":"Emons","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R33-6-20210129","first-page":"5439","article-title":"High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.","volume":"53","author":"Emons","year":"1993","journal-title":"Cancer Res"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/humrep\/12.4.769","article-title":"Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human preovulatory follicles.","volume":"12","author":"Brus","year":"1997","journal-title":"Hum Reprod"},{"key":"R35-6-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/molehr\/3.2.91","article-title":"Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues.","volume":"3","author":"Kobayashi","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"R36-6-20210129","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1073\/pnas.141048498","article-title":"A novel mammalian receptor for the evolutionarily conserved type II GnRH.","volume":"98","author":"Millar","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-6-20210129","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1006\/bbrc.2001.4678","article-title":"A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates.","volume":"282","author":"Neill","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R38-6-20210129","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2003-031871","article-title":"Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.","volume":"89","author":"Kim","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-6-20210129","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/jc.2004-1636","article-title":"Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation.","volume":"90","author":"Kim","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-6-20210129","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/en.2002-220622","article-title":"A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12.","volume":"144","author":"Morgan","year":"2003","journal-title":"Endocrinology"},{"key":"R41-6-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1677\/JME-06-0064","article-title":"Gene structure and promoter functional analysis of the marmoset type II GnRH receptor.","volume":"39","author":"Faurholm","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"R42-6-20210129","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/jc.2006-1147","article-title":"Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary.","volume":"91","author":"Choi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-6-20210129","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.1021\/bi800911z","article-title":"Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation.","volume":"47","author":"Coetsee","year":"2008","journal-title":"Biochemistry"},{"key":"R44-6-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.grf.0000197520.53682.32","article-title":"The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.","volume":"49","author":"Olivennes","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R45-6-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/acta.0.1280015","article-title":"Hormonal responses to the new potent GnRH antagonist Cetrorelix.","volume":"128","author":"Klingmuller","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R46-6-20210129","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2010-2239","article-title":"Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: Rct comparing recFSH initiated on cycle day 2 or 5.","volume":"96","author":"Blockeel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-6-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00404-005-0021-2","article-title":"GnRH-antagonists in reproductive medicine.","volume":"273","author":"Griesinger","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"R48-6-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1210\/jc.2008-1695","article-title":"Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.","volume":"94","author":"Struthers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-6-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2002-021065","article-title":"Suppression of a pituitary-ovarian axis by chronic oral administration of a novel nonpeptide gonadotropin-releasing hormone antagonist, TAK-013, in cynomolgus monkeys.","volume":"88","author":"Hara","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-6-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/me.2003-0101","article-title":"Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II.","volume":"18","author":"Wang","year":"2004","journal-title":"Mol Endocrinol"},{"key":"R51-6-20210129","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0196-9781(99)00130-8","article-title":"Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.","volume":"20","author":"Schally","year":"1999","journal-title":"Peptides"},{"key":"R52-6-20210129","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/pros.21169","article-title":"Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.","volume":"70","author":"Festuccia","year":"2010","journal-title":"Prostate"},{"key":"R54-6-20210129","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers.","volume":"13","author":"Duijkers","year":"1998","journal-title":"Hum Reprod"},{"key":"R55-6-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.fertnstert.2009.02.062","article-title":"Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study.","volume":"94","author":"Lin","year":"2010","journal-title":"Fertil Steril"},{"key":"R56-6-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0015-0282(00)01702-7","article-title":"Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.","volume":"75","author":"Erb","year":"2001","journal-title":"Fertil Steril"},{"key":"R57-6-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(16)57531-1","article-title":"Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).","volume":"63","author":"Nelson","year":"1995","journal-title":"Fertil Steril"},{"key":"R58-6-20210129","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(99)00413-6","article-title":"Pharmacokinetic and pharmacodynamic characteristics of ganirelix (AntagonOrgalutran). Part I. Absolute bioavailability of 0.25mg of ganirelix after a single subcutaneous injection in healthy female volunteers.","volume":"72","author":"Oberye","year":"1999","journal-title":"Fertil Steril"},{"key":"R59-6-20210129","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-releasing-hormone-receptor antagonists.","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"R60-6-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.301.1.95","article-title":"Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix.","volume":"301","author":"Broqua","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R61-6-20210129","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.fertnstert.2008.12.047","article-title":"The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.","volume":"93","author":"Taylor","year":"2010","journal-title":"Fertil Steril"},{"key":"R62-6-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF.","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R63-6-20210129","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1158\/0008-5472.CAN-04-1360","article-title":"Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.","volume":"64","author":"Maudsley","year":"2004","journal-title":"Cancer Res"},{"key":"R64-6-20210129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2108\/zsj.21.763","article-title":"Human type II GnRH receptor mediates effects of GnRH on cell proliferation.","volume":"21","author":"Enomoto","year":"2004","journal-title":"Zoolog Sci"},{"key":"R65-6-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.0.1510141","article-title":"Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.","volume":"151","author":"Grundker","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R66-6-20210129","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/edrv-2-4-437","article-title":"Extrapituitary actions of gonadotropin-releasing hormone.","volume":"2","author":"Hsueh","year":"1981","journal-title":"Endocr Rev"},{"key":"R67-6-20210129","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/endo-124-2-946","article-title":"Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes.","volume":"124","author":"Fekete","year":"1989","journal-title":"Endocrinology"},{"key":"R68-6-20210129","first-page":"430","article-title":"Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells.","volume":"80","author":"Minaretzis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R69-6-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00318886","article-title":"Immunolocalization of a gonadotropin-releasing hormone receptor site in murine endometrium that mediates apoptosis.","volume":"282","author":"Murdoch","year":"1995","journal-title":"Cell Tissue Res"},{"key":"R70-6-20210129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"R71-6-20210129","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"R72-6-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertil Steril"},{"key":"R73-6-20210129","first-page":"443","article-title":"Gonadotropin-releasing hormone antagonists instead of agonists: a change for the better Fertil S","volume":"76","author":"Blumenfeld","year":"2001","journal-title":"teril"},{"key":"R74-6-20210129","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review.","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R75-6-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis.","volume":"95","author":"Bodri","year":"2011","journal-title":"Fertil Steril"},{"key":"R76-6-20210129","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.fertnstert.2005.08.020","article-title":"Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.","volume":"85","author":"Giampietro","year":"2006","journal-title":"Fertil Steril"},{"key":"R77-6-20210129","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/humrep\/16.12.2533","article-title":"Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).","volume":"16","author":"Garcia-Velasco","year":"2001","journal-title":"Hum Reprod"},{"key":"R78-6-20210129","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.fertnstert.2009.09.032","article-title":"Gonadotropin releasing hormone antagonists suppress aromatase and anti-Mullerian hormone expression in human granulosa cells.","volume":"94","author":"Winkler","year":"2010","journal-title":"Fertil Steril"},{"key":"R79-6-20210129","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1210\/endo.140.8.6899","article-title":"The role of gonadotropin-releasing hormone in murine preimplantation embryonic development.","volume":"140","author":"Raga","year":"1999","journal-title":"Endocrinology"},{"key":"R80-6-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1472-6483(10)60632-3","article-title":"Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.","volume":"13","author":"Bukulmez","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R81-6-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.fertnstert.2007.02.017","article-title":"Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction.","volume":"89","author":"Bukulmez","year":"2008","journal-title":"Fertil Steril"},{"key":"R82-6-20210129","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/humrep\/dep181","article-title":"Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro.","volume":"24","author":"Klemmt","year":"2009","journal-title":"Hum Reprod"},{"key":"R83-6-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.12.015","article-title":"Effects of the gonadotropin-releasing hormone antagonist cetrorelix in the early postimplantation period on rat pregnancy.","volume":"155","author":"Tug","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R84-6-20210129","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/16.8.1588","article-title":"Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report.","volume":"16","author":"Olivennes","year":"2001","journal-title":"Hum Reprod"},{"key":"R85-6-20210129","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/17.8.2027","article-title":"Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix.","volume":"17","author":"Boerrigter","year":"2002","journal-title":"Hum Reprod"},{"key":"R86-6-20210129","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.fertnstert.2008.02.092","article-title":"Drugs in infertility and fetal safety.","volume":"89","author":"Elizur","year":"2008","journal-title":"Fertil Steril"},{"key":"R87-6-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1043-2760(97)00155-0","article-title":"Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells.","volume":"8","author":"Emons","year":"1997","journal-title":"Trends Endocrinol Metab"},{"key":"R88-6-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1460001","article-title":"Biology of the gonadotropin-releasing hormone system in gynecological cancers.","volume":"146","author":"Grundker","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"R89-6-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-0760(97)00189-1","article-title":"Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.","volume":"65","author":"Emons","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R90-6-20210129","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1210\/endo.142.6.8190","article-title":"Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.","volume":"142","author":"Grundker","year":"2001","journal-title":"Endocrinology"},{"key":"R91-6-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/gyno.2000.5863","article-title":"Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.","volume":"78","author":"Grundker","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R92-6-20210129","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/bcr2606","article-title":"Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.","volume":"12","author":"Grundker","year":"2010","journal-title":"Breast Cancer Res"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e328348a3ce","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:58Z","timestamp":1786044718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-201108000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e328348a3ce","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}